Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

123.54 +24.53 (+24.78%)
Official Closing Price Updated: 4:15 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
35 36 Next >
Dow Falls Over 100 Points; Amazon Posts Upbeat Q3 Results
 
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Why Illumina (ILMN) Stock Is Up Today
Shares of genomics company Illumina (NASDAQ:ILMN) jumped 22.4% in the afternoon session after it reported third-quarter 2025 financial results that beat profit expectations and raised its full-year... 
Via StockStory
Topics Economy Government World Trade
Earnings Scheduled For October 30, 2025
 
Via Benzinga
DNA Sequencing Firm Illumina Sees Strong Clinical Market Momentum, Stock Soars
Illumina shares rise after posting Q3 earnings and revenue above estimates, raising 2025 guidance and showing growth in clinical sequencing markets. 
Via Benzinga
Cloudflare Posts Upbeat Q3 Results, Joins Amazon, Roku, Coinbase, Atlassian And Other Big Stocks Moving Higher On Friday
 
Via Benzinga
ILMN Q3 Deep Dive: Clinical Sequencing Momentum and Cost Discipline Drive Outperformance
Genomics company Illumina (NASDAQ:ILMN) reported Q3 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $1.08 billion. Its non-GAAP profit of $1.34 per share... 
Via StockStory
Illumina Inc (NASDAQ:ILMN) Surpasses Profit Expectations in Q3 2025, Sparking 8.6% Stock Rally
Illumina (ILMN) Q3 2025 earnings beat profit estimates, sending shares up 8.6%. Strong EPS of $1.34 on flat revenue impressed investors. 
Via Chartmill
Topics Earnings
Illumina (NASDAQ:ILMN) Beats Q3 Sales Expectations
Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q3 CY2025, but sales were flat year on year at $1.08 billion. Its non-GAAP profit of $1.34 per share was 14.7% above... 
Via StockStory
What To Expect From Illumina’s (ILMN) Q3 Earnings
Genomics company Illumina (NASDAQ:ILMN) will be reporting results this Thursday after market close. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence
Nvidia Rockets Towards $5 Trillion Valuation, Reshaping the Global Tech Landscape
As of October 2025, Nvidia (NASDAQ: NVDA) stands on the precipice of a historic $5 trillion market valuation, a testament to its unparalleled dominance in the artificial intelligence (AI) and... 
Via MarketMinute
Topics Artificial Intelligence Economy
Looking Into Illumina Inc's Recent Short Interest
 
Via Benzinga
Undervalued Opportunity: A Deep Dive into Illumina Inc (ILMN)
Illumina (ILMN) presents a strong value investment case with attractive valuation, high profitability, and solid financial health, trading below industry peers. 
Via Chartmill
JPMorgan, Alibaba, Columbia Banking System And A Health Care Stock On CNBC's 'Final Trades'
JPMorgan is still Joshua Brown's favorite long-term investment, supported by strong Q3 earnings. Others also favor Illumina, Columbia & Alibaba. 
Via Benzinga
Cathie Wood Warns Wall Street Is Missing AI's Biggest Opportunity In Healthcare, Calling It 'Sleeper' Investment Poised For Massive Returns
Cathie Wood, CEO of Ark Invest, believes healthcare is the most profound application of AI and Wall Street is overlooking its potential. 
Via Benzinga
Topics Artificial Intelligence
10x Genomics, BioMarin Pharmaceutical, AMN Healthcare Services, Illumina, and Moderna Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. 
Via StockStory
Topics Economy Government World Trade
1 Volatile Stock to Target This Week and 2 Facing Headwinds
Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor... 
Via StockStory
Why Illumina (ILMN) Shares Are Falling Today
Shares of genomics company Illumina (NASDAQ:ILMN) fell 3.3% in the afternoon session after an analyst at Barclays maintained a cautious "Underweight" rating on the company. 
Via StockStory
Topics Artificial Intelligence
Decoding Life's Blueprint: New Tech Maps RNA-Protein Interactions, Unlocking Disease Cures
A monumental leap in biomedical research has been announced with the development of a breakthrough technology capable of mapping the entire intricate network of RNA-protein interactions within human... 
Via MarketMinute
Topics Artificial Intelligence Derivatives
Assessing Illumina: Insights From 9 Financial Analysts
 
Via Benzinga
Illumina's BioInsight Launch Sparks Optimism, Signals New Era for Genomic Data and AI
San Diego, CA – October 1, 2025 – Illumina, Inc. (NASDAQ: ILMN) saw its shares surge by 6.6% today following the announcement and immediate launch of its new business unit, BioInsight. This strategic... 
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
Thermo Fisher Scientific Soars on Strategic Wins, Market Optimism
Thermo Fisher Scientific Inc. (NYSE: TMO) experienced a robust surge in its stock value today, October 1, 2025, climbing an impressive 9.79% as market optimism swelled around a series of recent... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
Why Is Illumina (ILMN) Stock Rocketing Higher Today
Shares of genomics company Illumina (NASDAQ:ILMN) jumped 6.6% in the afternoon session after the company announced the launch of BioInsight, a new business unit designed to accelerate drug discovery... 
Via StockStory
Topics Artificial Intelligence Lawsuit Whistleblower
Illumina Stock Surged 6% Today – Here’s Why
The company announced that its new business will focus on developing data assets, software, and artificial intelligence to drive drug development. 
Via Stocktwits
Topics Artificial Intelligence
Nvidia's AI Reign Ignites Stock Futures: A Trillion-Dollar Trajectory Reshapes the Market
San Francisco, CA – September 30, 2025 – Nvidia Corporation (NASDAQ: NVDA) continues its unprecedented ascent, cementing its position as the undisputed titan of the artificial intelligence (AI) era. As... 
Via MarketMinute
Topics Artificial Intelligence Economy Supply Chain
Illumina Inc (NASDAQ:ILMN) Presents a Compelling Value Investment Case
Illumina (ILMN) presents a strong value case with attractive valuation metrics, high profitability, and solid financial health, making it a compelling stock for value investors. 
Via Chartmill
3 Healthcare Stocks That Fall Short
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID... 
Via StockStory
Topics Stocks
AI Takes Center Stage in Biodefense: DARPA's NODES Program Promises to Revolutionize Pandemic and Biowarfare Protection
In a groundbreaking leap for global health security, the Defense Advanced Research Projects Agency (DARPA) officially launched its Network of Optimal Dynamic Energy Signatures (NODES) program in July... 
Via MarketMinute
Topics Artificial Intelligence
Trump Administration Review Targets Medical Supply Chain Vulnerabilities
The U.S. Commerce Department, under the Trump administration, has launched a national security review of medical imports—including PPE, consumables, and medical devices—to assess reliance on foreign... 
Via Benzinga
Topics Economy Government Supply Chain
The Healthcare Horizon: Navigating Innovation, Policy Shifts, and Evolving Patient Care
The global healthcare industry is currently in the midst of a profound metamorphosis, characterized by a rapid influx of technological innovation, significant shifts in policy, and evolving patient... 
Via MarketMinute
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9
...
35 36 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.